Gut bacterial microbiota and obesity

Slides:



Advertisements
Similar presentations
Microbial culturomics: paradigm shift in the human gut microbiome study J.-C. Lagier, F. Armougom, M. Million, P. Hugon, I. Pagnier, C. Robert, F. Bittar,
Advertisements

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Laboratory diagnosis and biosafety issues of biological warfare agents
Vaccines for the elderly
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-C. Lagier  Clinical Microbiology and Infection 
The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection  R. Singh, M. Nieuwdorp, I.J.M.
Benchmarking inappropriate empirical antibiotic treatment
Approach to diagnosis of infective endocarditis
Varicella vaccination: a laboured take-off
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Changes in the intestinal microbiota from adulthood through to old age
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Non-antibiotic strategies for sepsis
An eye-catching acanthocephalan
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
B. Gordts  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
A case of pleurisy associated with antibodies to Rickettsia conorii
The practice of travel medicine in Europe
Systematic review of antibiotic consumption in acute care hospitals
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Benchmarking inappropriate empirical antibiotic treatment
Reducing antibiotic use in influenza: challenges and rewards
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Vaccines for the elderly
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Real-time comparative monitoring of the A/H1N1 pandemic in France
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Survival of rhinoviruses on human fingers
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L
Are we losing the fight against malaria one more time?
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Community-acquired acute bacterial meningitis in the elderly in Turkey
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Gut bacterial microbiota and obesity M. Million, J.-C. Lagier, D. Yahav, M. Paul  Clinical Microbiology and Infection  Volume 19, Issue 4, Pages 305-313 (April 2013) DOI: 10.1111/1469-0691.12172 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Factors affecting gut microbiota and obesity. Clinical Microbiology and Infection 2013 19, 305-313DOI: (10.1111/1469-0691.12172) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.